<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="contribute to the treatment of metabolic disorders such as non-alcoholic" exact="fatty liver disease" post="(NAFLD) [30] and diabetes [31], indicating their potential for"/>
 <result pre="to the treatment of metabolic disorders such as non-alcoholic fatty" exact="liver disease" post="(NAFLD) [30] and diabetes [31], indicating their potential for"/>
 <result pre="and diabetes [31], indicating their potential for preventing or treating" exact="hyperglycemia" post="and hyperlipidemia. Apart from polysaccharides, other molecular fractions isolated"/>
 <result pre="been found to possess health benefits such as anti-inflammation [36]," exact="hypoglycemia" post="[37], antitumor [38] and antioxidation [39]. This review gives"/>
 <result pre="effects of the D-fraction from G. frondosa on 165 advanced" exact="cancer" post="patients who received the D-fraction as crude powder tablets"/>
 <result pre="cells directly through the modulation of different cellular processes during" exact="cancer" post="development [48]. Zhao and coworkers found that a combination"/>
 <result pre="G. frondosa, was able to inhibit the proliferation of human" exact="colon cancer" post="HT-29 cells in vitro, with 180 Î¼g/mL as the"/>
 <result pre="frondosa, was able to inhibit the proliferation of human colon" exact="cancer" post="HT-29 cells in vitro, with 180 Î¼g/mL as the"/>
 <result pre="extracted from G. frondosa, showed an inhibitory effect on human" exact="lung cancer" post="cells at 4 Â°C. The inhibitory effect became lower"/>
 <result pre="from G. frondosa, showed an inhibitory effect on human lung" exact="cancer" post="cells at 4 Â°C. The inhibitory effect became lower"/>
 <result pre="frondosa could regulate gene expression involved in the apoptosis of" exact="breast cancer" post="cells so that cell proliferation was inhibited and the"/>
 <result pre="could regulate gene expression involved in the apoptosis of breast" exact="cancer" post="cells so that cell proliferation was inhibited and the"/>
 <result pre="antitumor effects as well due to their anti-proliferative activity against" exact="cancer" post="cells [32,71]. Table 7 summarizes the testing methods and"/>
 <result pre="of MM46 liver carcinoma, BEL 7402 cells and TMK-1 gastric" exact="cancer" post="cells. 4.2. Immunomodulation Immunomodulation is the most well-known effect"/>
 <result pre="in the treatment of viral infections, including those caused by" exact="hepatitis" post="B virus (HBV), enterovirus 71 (EV71), herpes simplex virus"/>
 <result pre="those caused by hepatitis B virus (HBV), enterovirus 71 (EV71)," exact="herpes simplex" post="virus type 1 (HSV-1) and human immunodeficiency virus (HIV)."/>
 <result pre="Mayell and coworkers reported a study on patients with chronic" exact="hepatitis" post="B. The results showed that patients who took G."/>
 <result pre="replication in vitro and reduced HSV-1 induced symptoms such as" exact="blepharitis" post="in a murine model [35]. In addition to antiviral"/>
 <result pre="A high FSG level is one of the characteristics of" exact="diabetes mellitus" post="sufferers and the influence on FSG level could directly"/>
 <result pre="found to be related with improved treatment of type 2" exact="diabetes mellitus" post="(T2DM) [107] and non-alcoholic fatty liver disease (NAFLD) [108]."/>
 <result pre="treatment of type 2 diabetes mellitus (T2DM) [107] and non-alcoholic" exact="fatty liver disease" post="(NAFLD) [108]. To evaluate the microbiota regulation activity of"/>
 <result pre="of type 2 diabetes mellitus (T2DM) [107] and non-alcoholic fatty" exact="liver disease" post="(NAFLD) [108]. To evaluate the microbiota regulation activity of"/>
 <result pre="shown the potential for treatment of metabolic diseases such as" exact="obesity" post="and diabetes [109]. Guo et al. obtained similar results,"/>
 <result pre="reducing Enterococcus, which was associated with the improved hyperlipidemia and" exact="hyperglycemia" post="in T2DM induced by streptozotocin and a high-fat diet"/>
 <result pre="found to regulate the gut microbiota of rats with non-alcoholic" exact="fatty liver disease" post="(NAFLD). Li and coworkers found that GFP could partly"/>
 <result pre="to regulate the gut microbiota of rats with non-alcoholic fatty" exact="liver disease" post="(NAFLD). Li and coworkers found that GFP could partly"/>
 <result pre="bacteria, namely, Firmicutes and Bacteroides, could have fat-lowering effects in" exact="obesity" post="treatment [106]. In addition, GFP supplementation significantly increased the"/>
 <result pre="frondosa: Grifola frondosa GFP: Grifola frondosa polysaccharide GRN: Grifolan HBV:" exact="hepatitis" post="B virus HFD: high-fat diet HIV: human immunodeficiency virus"/>
 <result pre="interleukins IR: insulin receptor IRS-1: insulin receptor substrate 1 HSV:" exact="herpes simplex" post="virus L. acidophilus: Lactobacillus acidophilus L. edodes: Lentinus edodes"/>
 <result pre="L. acidophilus: Lactobacillus acidophilus L. edodes: Lentinus edodes NAFLD: non-alcoholic" exact="fatty liver disease" post="NK cell: natural killer cell SBP: systolic blood pressure"/>
 <result pre="acidophilus: Lactobacillus acidophilus L. edodes: Lentinus edodes NAFLD: non-alcoholic fatty" exact="liver disease" post="NK cell: natural killer cell SBP: systolic blood pressure"/>
 <result pre="SBP: systolic blood pressure SSF: solid-state fermentation T2DM: type 2" exact="diabetes mellitus" post="TNF: tumor necrosis factors References References 1.MayellM.Maitake extracts and"/>
 <result pre="effect of d-fraction from Grifola frondosa and vitamin C on" exact="hepatocellular carcinoma" post="SMMC-7721 cellsIntegr. Cancer Ther.20171620521410.1177/153473541664467427151580 77.MasudaY.InoueH.OhtaH.MiyakeA.KonishiM.NanbaH.Oral administration of soluble Î²-glucans"/>
 <result pre="cold-water soluble polysaccharides from Grifola frondosaGlycoconj. J.20203710711710.1007/s10719-019-09894-y31823245 79.AlonsoE.N.OrozcoM.NietoA.E.BaloghG.A.Genes related to" exact="suppression" post="of malignant phenotype induced by Maitake D-Fraction in breast"/>
 <result pre="to suppression of malignant phenotype induced by Maitake D-Fraction in" exact="breast cancer" post="cellsJ. Med. Food20131660261710.1089/jmf.2012.022223875900 80.KodamaN.MurataY.AsakawaA.InuiA.HayashiM.SakaiN.NanbaH.Maitake D-Fraction enhances antitumor effects and"/>
 <result pre="suppression of malignant phenotype induced by Maitake D-Fraction in breast" exact="cancer" post="cellsJ. Med. Food20131660261710.1089/jmf.2012.022223875900 80.KodamaN.MurataY.AsakawaA.InuiA.HayashiM.SakaiN.NanbaH.Maitake D-Fraction enhances antitumor effects and"/>
 <result pre="a water-soluble extract from Maitake (Grifola frondosa) on human gastric" exact="cancer" post="cell linesOncol. Rep.20092261562010.3892/or_0000048019639212 82.KodamaN.KakunoT.NanbaH.Stimulation of the natural immune system"/>
 <result pre="for the treatment of Listeria-infected miceJpn. J. Pharmacol.20018732733210.1254/jjp.87.32711829152 85.GuC.-Q.LiJ.-W.ChaoF.-H.Inhibition of" exact="hepatitis" post="B virus by D-fraction from Grifola frondosa: Synergistic effect"/>
 <result pre="Obesity and NAFLDTurk. J. Gastroenterol.20142513314010.5152/tjg.2014.788625003671 109.YangJ.LeeY.KimY.LeeS.RyuS.FukudaS.HaseK.YangC.LimH.KimM.Gut commensal Bacteroides acidifaciens prevents" exact="obesity" post="and improves insulin sensitivity in miceMucosal Immunol.20171010411610.1038/mi.2016.4227118489 110.GuoW.-L.ChenM.PanW.-L.ZhangQ.XuJ.-X.LinY.-C.LiL.LiuB.BaiW.-D.ZhangY.-Y.et al.Hypoglycemic"/>
 <result pre="91.3% inhibition ratio [80] PS GFP-A In vitro testing of" exact="cancer" post="cell viability using MTT assay 150 Î¼g/mL at 48"/>
 <result pre="150 Î¼g/mL at 48 h, 50% inhibition (IC50) of human" exact="colon cancer" post="cells [65] PS MD-fraction In vivo assessing of inhibition"/>
 <result pre="Î¼g/mL at 48 h, 50% inhibition (IC50) of human colon" exact="cancer" post="cells [65] PS MD-fraction In vivo assessing of inhibition"/>
 <result pre="assessing of tumor inhibition rate in mice inoculated with S180" exact="sarcoma" post="cells Oral administration of 50, 100 and 200 mg/kg"/>
 <result pre="and 36.72% respectively [56] Glycoprotein GFG-3a In vitro testing of" exact="cancer" post="cell viability using MTT assay 20 Î¼g/mL against sarcoma"/>
 <result pre="of cancer cell viability using MTT assay 20 Î¼g/mL against" exact="sarcoma" post="180 cells, 92% inhibition ratio; 60 Î¼g/mL against BEL"/>
 <result pre="a phase-contrast microscope 10% w/v Maitake extract against TMK-1 gastric" exact="cancer" post="cell lines for 3 days, 90% inhibition ratio [81]"/>
</results>
